Braintree9.3.1.1 Product Disclosures

“Braintree 9.3.1.1 is ONC 2015 Edition compliant and has been certified by UL, an ONC-ACB, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.”

CERTIFICATION DATE:

04/18/2019

PRODUCT NAME:

BrainTREE

VERSION:

9.3.1.1

CERTIFICATION NUMBER:

15.02.02.1167.A095.01.00.1.190418

CRITERIA:

170.315(a)(1): Computerized provider order entry (CPOE) – medications
170.315(a)(3): Computerized provider order entry (CPOE) – diagnostic imaging
170.315(a)(5): Demographics 170.315(a)(6): Problem list
170.315(a)(7): Medication list 170.315(a)(8): Medication allergy list
170.315(a)(9): Clinical decision support (CDS) 170.315(a)(10): Drug-formulary and preferred
drug list checks
170.315(a)(11): Smoking status 170.315(a)(12): Family health history
170.315(a)(13): Patient-specific education resources 170.315(a)(14): Implantable device list
170.315(a)(15): Social, psychological, and behavioral data 170.315(b)(1): Transitions of care
170.315(b)(2): Clinical information reconciliation and incorporation 170.315(b)(3): Electronic prescribing
170.315(b)(4): Common Clinical Data Set summary record – create
170.315(b)(6): Data export 170.315(b)(7): Data segmentation for privacy – send
170.315(b)(8): Data segmentation for privacy – receive 170.315(b)(9): Care plan
170.315(c)(1): Clinical quality measures (CQMs) – record and export 170.315(h)(1): Direct Project
170.315(c)(3): Clinical quality measures (CQMs) – report 170.315(c)(4): Clinical quality measures (CQMs) – filter
170.315(d)(1): Authentication, access control, authorization 170.315(d)(2): Auditable events and tamper-resistance
170.315(d)(3): Audit report(s) 170.315(d)(4): Amendments
170.315(d)(5): Automatic access time-out 170.315(d)(6): Emergency access
170.315(d)(7): End-user device encryption 170.315(d)(8): Integrity
170.315(d)(9): Trusted connection 170.315(d)(10): Auditing actions on health information
170.315(d)(11): Accounting of disclosures 170.315(e)(1): View, download, and transmit to 3rd party
170.315(e)(2): Secure messaging 170.315(e)(3): Patient health information capture
170.315(f)(7): Transmission to public health
agencies – health care surveys
170.315(g)(2): Automated measure calculation 170.315(g)(3): Safety-enhanced design
170.315(g)(4): Quality management system 170.315(g)(5): Accessibility-centered design
170.315(g)(6): Consolidated CDA creation performance 170.315(g)(7): Application access – patient selection
170.315(g)(8): Application access – data category request 170.315(g)(9): Application access – all data request
170.315(a)(2): Computerized provider order entry (CPOE) – laboratory 170.315(f)(1): Transmission to immunization registries
170.315(a)(4): Drug-drug, drug-allergy interaction checks for CPOE
170.315(f)(2): Transmission to public health agencies – syndromic surveillance
170.315(b)(5): Common Clinical Data Set summary record – receive
170.315(c)(2): Clinical quality measures (CQMs) – import and calculate
170.315(f)(3): Transmission to public health agencies – reportable laboratory
tests and value/results
170.315(f)(5): Transmission to public health agencies – electronic case reporting
170.315(f)(6): Transmission to public health agencies – antimicrobial use
and resistance reporting

CQMs:

Version Quality Measure 170.315 (c)(1) 170.315 (c)(2) 170.315 (c)(3) 170.315 (c)(4)
CMS2v7 Preventive Care and Screening: Screening for Depression and Follow-Up Plan . . . .
CMS66v6 Functional Status Assessment for Total Knee Replacement . . . .
CMS69v6 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan . . . .
CMS82v5 Maternal Depression Screening . . . .
CMS90v7 Functional Status Assessments for Congestive Heart Failure . . . .
CMS117v6 Childhood Immunization Status . . . .
CMS123v6 Diabetes: Foot Exam . . . .
CMS124v6 Cervical Cancer Screening . . . .
CMS125v6 Breast Cancer Screening . . . .
CMS127v6 Pneumococcal Vaccination Status for Older Adults . . . .
CMS130v6 Colorectal Cancer Screening . . . .
CMS131v6 Diabetes: Eye Exam . . . .
CMS135v6 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) . . . .
CMS137v6 Initiation and Engagement of Alcohol and Other Drug Dependence Treatment . . . .
CMS139v6 Falls: Screening for Future Fall Risk . . . .
CMS144v6 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) . . . .
CMS145v6 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) . . . .
CMS146v6 Appropriate Testing for Children with Pharyngitis . . . .
CMS153v6 Chlamydia Screening for Women . . . .
CMS155v6 Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents . . . .
CMS161v6 Adult Major Depressive Disorder (MDD): Suicide Risk Assessment . . . .
CMS164v6 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet . . . .
CMS165v6 Controlling High Blood Pressure . . . .
CMS166v7 Use of Imaging Studies for Low Back Pain . . . .

ADDITIONAL SOFTWARES USED FOR CERTIFICATION:

Additional Software Name Associated Criteria Functionality Provided
Dr First 315a1:315a4:315a10:315b03 eprescribing
EMR Direct 315b01:315e01:315h01 Interoperability Engine
Medline Plus 315a13 Patient Specific Education Resources
Net Time || 315d02:315d03:315e01 NTP

Usability Report:

Additional Fee

Additional fee is charged for eprescription license per provider.

Known Limitations

Braintree EHR is a 2015 Edition certified Health IT product. For more details on Braintree EHR Cost and Limitations, please refer to the Braintree Costs and Limitations per ONC.

Quality Management System

Standard Description Applicable Criteria
ISO 9001: 2015 N/A All

None

Accessibility Standard

WCAG 2.0 AA

Access API TOU
Access API Documentation